Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial.

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Trials

Background:

• Electroconvulsive therapy (ECT) is a recognized effective treatment for major depressive disorder.
• Ongoing research aims to optimize ECT efficacy and minimize cognitive side effects through technical advancements.

Purpose of the Study:

• To compare the antidepressant efficacy and cognitive impact of a novel bifrontal electrode placement against traditional bitemporal and right unilateral placements in ECT.
• Evaluate the effectiveness of different ECT electrode placements for treating major depression.

Main Methods:

• A multicenter, randomized, double-blind, controlled trial involving 230 patients with unipolar or bipolar major depression.
• Patients were assigned to one of three ECT electrode placements: bifrontal, bitemporal, or right unilateral, with specific electrical dosing parameters.

Main Results:

• All three electrode placements demonstrated clinically and statistically significant antidepressant outcomes.
• Remission rates were 55% (right unilateral), 61% (bifrontal), and 64% (bitemporal).
• Bitemporal placement showed a more rapid decrease in symptom severity during early treatment; cognitive assessments revealed minimal differences between placements.

Conclusions:

• Bifrontal, bitemporal, and right unilateral ECT electrode placements are all highly effective antidepressant treatments with appropriate electrical dosing.
• Bitemporal placement is recommended for urgent clinical situations due to faster symptom reduction.
• The bifrontal electrode placement exhibits a cognitive profile comparable to the bitemporal placement.